The House passed the Stop Insider Trading Act (H.R. 7008) in late July 2026 on a 232-198 vote, advancing the first major floor action on restricting congressional stock purchases by members, spouses, and dependents while adding advance-notice rules for sales. The measure now sits in the Senate after referral, where companion versions introduced earlier in the 119th Congress have seen little movement beyond initial committee referrals. With only five months remaining before the 2027 cutoff and no scheduled floor consideration or bipartisan agreement on a final package, traders see slim odds of enactment. Senate leaders have signaled skepticism over scope and timing, consistent with historical patterns where ethics reforms face procedural holds even after House approval. Recent developments underscore the gap between House momentum and Senate gridlock.